VC  Research Corporation Technologies

http://www.rctech.com





     Office Locations:

5210 East Williams Circle, Suite 240
Tucson, AZ 85711-4410
Phone: 520-748-4400
Fax: 520-748-0025

Get all office locations for this firm with a National Database subscription or Southern California Database subscription.
 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Founded in 1987, Research Corporation Technologies in Tucson, Ariz., is a technology investment and management company that provides early-stage funding and development for promising biomedical companies and technologies. RCT focuses on technology investments with origins from universities and research institutions worldwide. The RCT BioVentures program is the vehicle through which RCT invests in start-up or early-stage companies with technologies that promise patented biomedical products with a clear competitive advantage. RCT has assets of more than $200 million to advance technology development through flexible, long-term investment options. The firm's initial financial commitment to its portfolio companies usually ranges from several hundred thousand dollars to several million dollars, and the firm reserves additional funds for the subsequent funding of successful companies. Within the United Kingdom and Australia, RCT BioVentures invests through Cambridge Research BioVentures Ltd. (CRB) and BioVentures Australia Pty. RCT launched CRB with Cambridge-based Emerging Technology Services Limited (ETS) in 2000 to support early development of promising biomedical and life sciences discoveries in the United Kingdom. Start-up Australia and RCT formed BioVentures Australia in March 1999 to invest in life science and medical technologies originating in Australia. Current interests include new life-sciences platforms, and preclinical and clinical-stage therapeutics, devices and diagnostics.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Southern California Database subscription.
    Chad W. Souvignier Managing Director
    Christopher P. Martin President
    David Bramhill Director
    David Wiersma Senior Associate
    Gary M. Munsinger Chairman of the Board

     

    Portfolio companies include:


      Aeson Therapeutics
        web link


      Alerion Biomedical
        web link


      APT Pharmaceuticals
        web link


      BioCision
        web link


      Catalyst Biosciences
        web link


      Clear Catheter Systems
        web link


      Cylene Pharmaceuticals
        web link


      CyMedica Orthopedics
        web link


      Esperance Pharmaceuticals
        web link


      Fullerene International
        web link


      Jenrin Discovery
        web link


      Kerberos Proximal Solutions
        web link


      Lacoste & Romberg Scintrex
        web link


      NP Photonics
        web link


      OncoGenex Technologies
        web link


      Option3
        web link


      OrthAlign
        web link


      ParinGenix
        web link


      Peptech Ltd.
        web link


      Sertoli Technologies
        web link


      Spirogen Ltd.
        web link


      Therapeutic Human Polyclonals
        web link


      Varix Medical
        web link


      VasoNova
        web link


     

    Recent News:


      There is no recent news for Research Corporation Technologies.